Lisanti Capital Growth LLC Acquires New Shares in Hinge Health Inc. $HNGE

Lisanti Capital Growth LLC bought a new position in Hinge Health Inc. (NYSE:HNGE) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 59,700 shares of the company’s stock, valued at approximately $3,089,000. Lisanti Capital Growth LLC owned about 0.08% of Hinge Health as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in HNGE. Emerald Advisers LLC bought a new position in shares of Hinge Health during the 2nd quarter valued at $108,000. Mark Sheptoff Financial Planning LLC purchased a new position in Hinge Health in the second quarter worth about $114,000. FNY Investment Advisers LLC bought a new stake in shares of Hinge Health during the 2nd quarter valued at about $310,000. Strategic Blueprint LLC purchased a new stake in shares of Hinge Health during the 2nd quarter valued at about $346,000. Finally, CHURCHILL MANAGEMENT Corp bought a new position in shares of Hinge Health in the 2nd quarter worth approximately $828,000.

Wall Street Analysts Forecast Growth

HNGE has been the topic of several analyst reports. Baird R W upgraded shares of Hinge Health to a “hold” rating in a research note on Friday, September 5th. JMP Securities boosted their price target on Hinge Health from $58.00 to $65.00 and gave the company a “market outperform” rating in a report on Wednesday, August 6th. Barclays raised their price objective on Hinge Health from $62.00 to $65.00 and gave the stock an “overweight” rating in a research note on Wednesday. Citigroup initiated coverage on shares of Hinge Health in a research note on Monday, July 14th. They set an “outperform” rating on the stock. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Hinge Health in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Hinge Health has a consensus rating of “Moderate Buy” and a consensus price target of $59.93.

Hinge Health Stock Up 0.9%

Shares of HNGE opened at $44.43 on Friday. Hinge Health Inc. has a 1 year low of $33.42 and a 1 year high of $62.18. The firm’s 50 day moving average is $52.43.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to the consensus estimate of $142.44 million. The business’s revenue for the quarter was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.